These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26433207)

  • 21. Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study.
    Ting RD; Keech AC; Drury PL; Donoghoe MW; Hedley J; Jenkins AJ; Davis TM; Lehto S; Celermajer D; Simes RJ; Rajamani K; Stanton K;
    Diabetes Care; 2012 Feb; 35(2):218-25. PubMed ID: 22210576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.
    Ghouri N; Preiss D; Sattar N
    Hepatology; 2010 Sep; 52(3):1156-61. PubMed ID: 20658466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
    Kunutsor SK; Apekey TA; Khan H
    Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study.
    Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Blokzijl H; Gansevoort RT; Dullaart RP
    Atherosclerosis; 2015 Nov; 243(1):138-47. PubMed ID: 26386210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study.
    Morling JR; Fallowfield JA; Williamson RM; Robertson CM; Glancy S; Guha IN; Strachan MW; Price JF
    Diabetologia; 2015 Jul; 58(7):1484-93. PubMed ID: 25820150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans.
    Yun KE; Shin CY; Yoon YS; Park HS
    Atherosclerosis; 2009 Aug; 205(2):533-7. PubMed ID: 19159884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2007 Jun; 56(6):792-8. PubMed ID: 17512312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver enzymes and incident diabetes in China: a prospective analysis of 10 764 participants in the Guangzhou Biobank Cohort Study.
    Xu L; Jiang CQ; Schooling CM; Zhang WS; Cheng KK; Lam TH
    J Epidemiol Community Health; 2015 Nov; 69(11):1040-4. PubMed ID: 26139641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Field, a randomized clinical trial of cardiovascular prevention with fenofibrate in type 2 diabetes].
    Radermecker RP; Scheen AJ
    Rev Med Liege; 2005 Dec; 60(12):957-61. PubMed ID: 16457397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of increasing alanine aminotransferase levels within normal range on incident diabetes.
    Wang CS; Chang TT; Yao WJ; Wang ST; Chou P
    J Formos Med Assoc; 2012 Apr; 111(4):201-8. PubMed ID: 22526208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of fenofibrate in clinical practice.
    Zambon A; Cusi K
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S15-20. PubMed ID: 17935056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study.
    Cao JY; Waldman B; O'Connell R; Sullivan DR; Scott RS; Aryal N; Gebski V; Marschner I; Taskinen MR; Simes JR; McGill N; Jenkins AJ; Keech AC;
    Diabetes Obes Metab; 2020 Aug; 22(8):1388-1396. PubMed ID: 32243036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.
    André P; Balkau B; Born C; Charles MA; Eschwège E;
    Diabetologia; 2006 Nov; 49(11):2599-603. PubMed ID: 16969645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome.
    Kanbay A; Kaya E; Buyukoglan H; Ozdogan N; Kaya MG; Oymak FS; Gulmez I; Demir R; Kokturk O
    Respir Med; 2011 Apr; 105(4):637-42. PubMed ID: 21183328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
    Chan KH; O'Connell RL; Sullivan DR; Hoffmann LS; Rajamani K; Whiting M; Donoghoe MW; Vanhala M; Hamer A; Yu B; Stocker R; Ng MK; Keech AC;
    Diabetologia; 2013 Apr; 56(4):724-36. PubMed ID: 23322233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population: The Study of Health in Pomerania (SHIP).
    Markus MR; Meffert PJ; Baumeister SE; Lieb W; Siewert U; Schipf S; Koch M; Kors JA; Felix SB; Dörr M; Targher G; Völzke H
    Atherosclerosis; 2016 Feb; 245():123-31. PubMed ID: 26722832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study.
    Sato KK; Hayashi T; Nakamura Y; Harita N; Yoneda T; Endo G; Kambe H
    Diabetes Care; 2008 Jun; 31(6):1230-6. PubMed ID: 18316395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes.
    Ong KL; Rye KA; O'Connell R; Jenkins AJ; Brown C; Xu A; Sullivan DR; Barter PJ; Keech AC;
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4701-8. PubMed ID: 23144467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated liver enzymes are related to progression to impaired glucose tolerance in Japanese men.
    Oka R; Aizawa T; Yagi K; Hayashi K; Kawashiri M; Yamagishi M
    Diabet Med; 2014 May; 31(5):552-8. PubMed ID: 24151911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.